Benzinga - by Avi Kapoor, Benzinga Staff Writer.
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 80 points on Wednesday.
Shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) fell sharply during Wednesday’s session after the company announced a clinical program update for LN-145 TIL therapy in non-small lung cancer (NSCLC).
The FDA placed a clinical hold on the IOV-LUN-202 trial on December 22, 2023, in response to a recently reported Grade 5 (fatal) serious adverse event potentially related to the non-myeloablative lymphodepletion pre-conditioning regimen.
Iovance Biotherapeutics shares dipped 20.4% to $7.07 on Wednesday.
Here are some other big stocks recording gains in today’s session.
- Nukkleus Inc. (NASDAQ: NUKK) shares declined 28.8% to $2.60 after jumping around 11% on Tuesday.
- GreenTree Hospitality Group Ltd. (NYSE: GHG) fell 10% to $3.69.
- InnSuites Hospitality Trust (NYSE: IHT) dipped 8.6% to $1.4250.
- LanzaTech Global, Inc. (NASDAQ: LNZA) fell 7.6% to $5.00.
- Life Time Group Holdings, Inc. (NYSE: LTH) fell 6.9% to $14.30. On Dec 22, Life Time Group Holdings agreed with company’s CFO, Robert Houghton that he will resign as CFO.
- Cheche Group Inc. (NASDAQ: CCG) fell 6.3% to $6.51.
- Canopy Growth Corporation (NASDAQ: CGC) declined 6.2% to $5.31.
- Velocity Financial, Inc. (NYSE: VEL) fell 4.8% to $15.62.
- The Beauty Health Company (NASDAQ: SKIN) fell 4.8% to $3.0850.
- NetEase, Inc. (NASDAQ: NTES) fell 4.2% to $88.30 on continued volatility amid regulatory developments in China's gaming sector.
- NIO Inc. (NYSE: NIO) fell 4.1% to $8.95 after rising more than 10% on Tuesday. Nio stock raced higher to start the week after the company launched its new ET9 sedan at its Nio Day event over the weekend.
Now Read This: Ethereum Moves Higher; Bitcoin SV Emerges As Top Gainer
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.